January 8th 2025
The FDA approved the addition of Guillain-Barré syndrome warnings for Abrysvo and Arexvy, citing postmarketing data suggesting an increased risk.
January 7th 2025
The first death of an American from the H5N1 virus was reported in Louisiana on Monday, though authorities maintain the risk of widespread infection remains low.
January 6th 2025
Sanofi and SK bioscience expand collaboration on pneumococcal conjugate vaccines, including a 21-valent candidate for pediatric populations.
December 18th 2024
Your daily dose of the clinical news you may have missed.
December 10th 2024
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 25, 2022
Data from the CDC on US vaccination and booster shot rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Three Flu Season Imperatives: Vaccinate the Young, the Old, and Everyone in Between
Influenza season in the southern hemisphere is "substantial," says Dr William Schaffner. To prepare: "Vaccinate, vaccinate, vaccinate!"
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 24, 2022
COVID-19, Flu, or Both—There are Always Patients on the Fence
The patients on the vaccine fence are the ones that take the extra time and, over time, an added measure of patience for the clinician.
Moderna Requests Emergency Use Authorization for COVID-19 Bivalent Vaccine
Moderna filed with the FDA for emergency use authorization of a 50-µg dose of a BA.4./BA.5 Omicron-targeting bivalent booster vaccine for those aged ≥18 years.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 23, 2022
Pfizer-BioNTech Request EUA for Bivalent COVID-19 Vaccine for Fall
Pfizer-BioNTech filed with the FDA for emergency use authorization of a 30-mcg dose of an Omicron BA.4.BA.5-adapted vaccine for those aged ≥12 years.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 22, 2022
HHS: Monkeypox Vaccine Production to Begin in the US as Cases Surpass 14 000
Federal officials have announced an agreement between Jynneos manufacturer Bavarian Nordic and a Michigan-based drug maker to "fill and finish" US-owned doses.
New Real-world Study Finds Average Length of COVID-19 Infectiousness is 5 Days
A new real-world study found that two-thirds of patients with COVID-19 were still infectious 5 days and one-fourth at 7 days after symptom onset.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 19, 2022
William Schaffner, MD: "If It's Not Flu and It's Not COVID, It's Probably RSV"
Respiratory virus season is top of mind for Schaffner, medical director of the National Foundation for Infectious Diseases, and he says it's going to be a challenge.
COVID-19 Vaccine Risk Presented in Context Could Improve Uptake
Pair the risk of side effects associated with a COVID-19 shot with the risk of death in a car accident and see what happens. It worked in this study.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 18, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 16, 2022
FDA: Repeat At-home COVID-19 Antigen Tests to Reduce Risk of False Negative Result
The FDA now recommends serial testing following a negative result on any at-home COVID-19 antigen test to reduce the risk of a false negative result.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 15, 2022
New CDC COVID-19 Guidelines Reduce Quarantine Requirement after Exposure
After exposure to COVID-19, asymptomatic individuals in low-risk settings no longer need to quarantine, says the CDC; masking is still recommended.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 12, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 11, 2022
5 Clinical Updates in Tick-borne Disease Research
Lyme disease vaccine being tested in phase 3 trial, Lyme disease diagnoses up 357%, and 3 more updates on tick-borne diseases.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 10, 2022
Less Than One-third of Adults with HCV Get Timely Treatment, According to New CDC Report
Timely initiation of DAA treatment, regardless of insurance type, is crucial in reducing HCV-related death, disparity, and transmission, concluded CDC researchers.
FDA EUA for Monkeypox Virus Vaccine Expands Available Doses by 5-Fold
A smaller dose given by intradermal injection will expand the total US supply by a factor of 5, FDA says.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 9, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 6, 2022
Vaccine Flashcards: 4 Respiratory Virus Updates
Influenza, SARS-CoV-2, and RSV: 4 drug makers have all 3 viruses targeted for vaccines, alone and in combination. Click through the flash-card update.
Refugee Immunization Requirements: A Quick Quiz
Refresh your memory on refugee immunization recommendations with a 2-question quiz based on a patient scenario.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 5, 2022
Monkeypox Declared US Public Health Emergency by HHS
Monkeypox will now be treated as a public health emergency in the US where the outbreak has become the largest in the world, according to authorities.